Great Collaboration and Important Update as TIRmed Pharma Strengthens Partnership with Zelmic
Zelmic is proud to announce the continued and expanded collaboration with TIRmed Pharma in the development of TIR-C, a novel topical oligonucleotide-based treatment for atopic dermatitis. This innovative drug candidate is designed to address the underlying causes of the disease, not just its symptoms, and has shown highly promising preclinical results — with five topical…
Continue Reading
